<SEC-DOCUMENT>0001576280-26-000004.txt : 20260112
<SEC-HEADER>0001576280-26-000004.hdr.sgml : 20260112
<ACCEPTANCE-DATETIME>20260112060459
ACCESSION NUMBER:		0001576280-26-000004
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20260111
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260112
DATE AS OF CHANGE:		20260112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Guardant Health, Inc.
		CENTRAL INDEX KEY:			0001576280
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				454139254
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38683
		FILM NUMBER:		26524533

	BUSINESS ADDRESS:	
		STREET 1:		3100 HANOVER STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		855-698-8887

	MAIL ADDRESS:	
		STREET 1:		3100 HANOVER STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gh-20260111.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ba4f1-180a-778a-9484-b3eaf10c68d4,g:f03674a2-080d-403e-9182-da3a975c6624,d:8151468a6bb443df9b5c871d210f5d32-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>gh-20260111</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001576280</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="gh-20260111.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001576280</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-11</xbrli:startDate><xbrli:endDate>2026-01-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8151468a6bb443df9b5c871d210f5d32_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:144%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:144%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:144%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:144%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:144%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:144%">Pursuant to Section&#160;13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:144%">of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:144%">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">January 11, 2026</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">GUARDANT HEALTH, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:144%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.080%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.700%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.080%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.700%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38683</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">45-4139254</ix:nonNumeric></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">of incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Commission</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">3100 Hanover Street</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Palo Alto</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">94304</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:144%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">855</ix:nonNumeric>-<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12"><ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">698-8887</ix:nonNumeric></ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:144%">(Registrant&#8217;s telephone number, include area code)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:144%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.894%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#211d1e;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:209%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.690%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, $0.00001 par value per share</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">GH</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">The Nasdaq Global Select Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:144%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934&#160;(&#167;240.12b-2&#160;of this chapter).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:144%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:144%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:144%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9744;</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:9pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8151468a6bb443df9b5c871d210f5d32_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Item 2.02.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Results of Operations and Financial Conditions</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:115%">. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On January 11, 2026, Guardant Health, Inc. (the &#8220;Company&#8221;) announced certain preliminary unaudited financial information for the quarter and full year ended December 31, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Item 7.01.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Regulation FD Disclosure</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:115%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company will post the presentation that it will present at the 2026 J.P. Morgan Healthcare Conference on January 12, 2026 to the Company&#8217;s website, www.guardanthealth.com, on the &#8220;Events &amp; Presentations&#8221; page under the &#8220;Investors&#8221; tab.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information furnished in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01  Financial Statements and Exhibits.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.5pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.5pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="gh-01122026xexhibit991.htm">Press Release of Guardant Health, Inc., dated January 11, 2026</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8151468a6bb443df9b5c871d210f5d32_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-bottom:8pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="margin-bottom:6pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:5.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.390%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">GUARDANT HEALTH, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">January 12, 2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael Bell</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Michael Bell</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer and Principal Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>gh-01122026xexhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i04772a01ac644df7bec1e7e1d83619db_1"></div><div style="min-height:86.4pt;width:100%"><div style="margin-bottom:8pt;text-align:center"><img alt="guardantlogoa01.gif" src="guardantlogoa01.gif" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:282px"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%"> </font></div></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">Fourth quarter revenue growth of 39% driven by strong Oncology and Screening volume  </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">PALO ALTO, Calif.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> January&#8239;11, 2026 &#8211; Guardant Health, Inc. (Nasdaq&#58; GH), a leading precision oncology company, today announced preliminary, unaudited results for the quarter and full year ended December 31, 2025. </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Fourth quarter 2025 preliminary unaudited financial results </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">For the three-month period ended December 31, 2025, as compared to the same period of 2024&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Total revenue of approximately $280 million, an increase of 39% </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Reported approximately 79,000 oncology tests, an increase of 38%  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Reported approximately 38,000 Shield screening tests, compared to 6,400 tests in the prior year period  </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Full year 2025 preliminary unaudited financial results  </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">For the twelve-month period ended December 31, 2025, as compared to the same period of 2024&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Total revenue of approximately $981 million, an increase of 33% </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Reported approximately 276,000 oncology tests, an increase of 34%  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Reported approximately 87,000 Shield screening tests </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;2025 was a breakout year for Guardant, with total revenue growth accelerating to 33% year-over-year,&#8221; said Helmy Eltoukhy, co-founder and co-CEO. &#8220;We saw exceptional volume growth in Oncology over the last year, primarily driven by pioneering innovation from our Smart Platform and best-in-class commercial execution. We expect this momentum to continue throughout the year with the launch of multiple groundbreaking products that will fuel the next phase of growth in our Oncology business.&#8221;  </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;We are incredibly proud of Shield's strong momentum as we continue to strengthen our leadership in the blood-based colorectal cancer screening market, with Shield positioned as one of the most successful diagnostic launches to date,&#8221; said AmirAli Talasaz, co-founder and co-CEO. &#8220;Since FDA approval, nearly 100,000 patients have been screened with Shield. We have now expanded Shield to include multi-cancer detection findings, further enhancing the clinical value of the platform for both patients and physicians. Together, these milestones will further advance the fight against cancer in 2026 and beyond.&#8221; </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Preliminary unaudited free cash flow was approximately negative $54 million for the fourth quarter of 2025, and approximately negative $233 million for the full year 2025. Cash, cash equivalents, restricted cash, and marketable debt securities were approximately $1.3 billion as of December 31, 2025. </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font><br></font></div><div style="height:14.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div style="margin-bottom:8pt;text-align:center"><img alt="guardantlogoa01.gif" src="guardantlogoa01.gif" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:282px"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%"> </font></div></div><div style="margin-bottom:3pt;margin-top:6pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Guardant Health has not completed preparation of its financial statements for the fourth quarter or full year of 2025. The revenue, test volumes and free cash flow presented in this release for the fourth quarter and the year ended December 31, 2025, are preliminary and unaudited and are thus inherently uncertain and subject to change as we complete our financial results. The company is in the process of completing its customary year-end close and review procedures as of and for the year ended December 31, 2025, and there can be no assurance that final results for this period will not differ from these estimates. During the preparation of Guardant Health&#8217;s consolidated financial statements and related notes as of and for the year ended December 31, 2025, the company&#8217;s independent registered public accountants may identify items that could cause final reported results to be materially different from the preliminary financial estimates presented herein. </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Upcoming events </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Guardant Health plans to report its fourth quarter and full year audited financial results for the period ended December 31, 2025, during its February 2026 earnings call. </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">About Guardant Health </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on&#8239;LinkedIn,&#8239;X (Twitter)&#8239;and&#8239;Facebook. </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Forward Looking Statements </font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the potential utilities, values, benefits and advantages of Guardant Health&#8217;s liquid biopsy tests or assays, which involve risks and uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors. These and additional risks and uncertainties that could affect Guardant Health&#8217;s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operation&#8221; and elsewhere in its Annual Report on Form 10-K for the year ended December 31, 2024, and in its other reports filed with or furnished to the Securities and Exchange Commission thereafter. The forward-looking statements in this press release are based on information available to Guardant Health as of the date hereof, and Guardant Health disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Guardant Health&#8217;s views as of any date subsequent to the date of this press release. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">Zarak Khurshid</font></div><div><font style="color:#0563c1;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">investors&#64;guardanthealth.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">Media Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">Meaghan Smith</font></div><div><font style="color:#0563c1;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">press&#64;guardanthealth.com</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">+1 650-647-3711</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Source&#58; Guardant Health, Inc. </font></div><div style="height:14.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div style="margin-bottom:8pt;text-align:center"><img alt="guardantlogoa01.gif" src="guardantlogoa01.gif" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:282px"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%"> </font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">Reconciliation of Free Cash Flow to Net Cash Used in Operating Activities  </font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">(unaudited) </font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">(in millions) </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.268%"><tr><td style="width:1.0%"></td><td style="width:33.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.773%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.773%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.773%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:133%">Three Months Ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:133%">Twelve Months Ended December 31,</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:133%">2025</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:133%">2024</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:133%">2025</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:133%">2024</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%">Net cash used in operating activities</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(26)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(64)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(185)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(240)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">Purchases of property and equipment   </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(28)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(19)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(48)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(35)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">Free cash flow</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(54)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(83)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(233)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">(275)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:14.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>gh-20260111.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ba4f1-180a-778a-9484-b3eaf10c68d4,g:f03674a2-080d-403e-9182-da3a975c6624-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gh="http://guardanthealth.com/20260111" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://guardanthealth.com/20260111">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gh-20260111_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gh-20260111_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://guardanthealth.com/role/DocumentandEntityInformationDocument">
        <link:definition>0000001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>gh-20260111_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ba4f1-180a-778a-9484-b3eaf10c68d4,g:f03674a2-080d-403e-9182-da3a975c6624-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_019ba4f1-180a-77e6-8689-6fb3ea3a1d03_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_019ba4f1-180a-7500-b426-25558cf677e0_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019ba4f1-180a-7dfe-97f8-f4d161995bea_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_019ba4f1-180a-7307-8c07-33b128996ba2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019ba4f1-180a-7497-aa6a-1bf943437f4a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_019ba4f1-180a-7c66-9942-e37bf1d3071d_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019ba4f1-180a-7913-b11f-316fce0038bb_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019ba4f1-180a-7cc3-a1e2-a66ec37ea423_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_019ba4f1-180a-7bca-8deb-2e3f281ae720_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019ba4f1-180a-765a-8eb5-b24c4acfd20e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019ba4f1-180a-7fa5-9631-9515088f2520_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019ba4f1-180a-7a78-8593-cd170fe556ef_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019ba4f1-180a-71e7-b815-d9d3c5927781_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019ba4f1-180a-7f44-89d9-668754687302_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019ba4f1-180a-7f9e-9894-8cd2b5e2175d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019ba4f1-180a-7d82-be51-e9f27823ed68_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019ba4f1-180a-7cf0-a7f3-8b7a62fff3d1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019ba4f1-180a-70a2-8ca7-c5445538beca_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019ba4f1-180a-76a1-9b0e-53caba55bf8d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019ba4f1-180a-740d-b8cd-1de9a02d8ffb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019ba4f1-180a-7af6-8c74-2516eab4daef_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019ba4f1-180a-775b-a9bd-e00bc619ca4d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019ba4f1-180a-7614-b39b-5959ed956c5c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>gh-20260111_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ba4f1-180a-778a-9484-b3eaf10c68d4,g:f03674a2-080d-403e-9182-da3a975c6624-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://guardanthealth.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="gh-20260111.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://guardanthealth.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019ba4f1-180a-70ff-9e78-d16178efddaa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_DocumentType_019ba4f1-180a-70ff-9e78-d16178efddaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019ba4f1-180a-7cf7-a141-b0c2de5f5374" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_DocumentPeriodEndDate_019ba4f1-180a-7cf7-a141-b0c2de5f5374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019ba4f1-180a-71e5-844c-d0e662a297af" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_EntityRegistrantName_019ba4f1-180a-71e5-844c-d0e662a297af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019ba4f1-180a-744f-93f9-29637ef0706e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_EntityCentralIndexKey_019ba4f1-180a-744f-93f9-29637ef0706e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019ba4f1-180a-7dda-a3d6-9a3904c55a75" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_AmendmentFlag_019ba4f1-180a-7dda-a3d6-9a3904c55a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019ba4f1-180a-7e7a-87c7-38d38f54fa10" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019ba4f1-180a-7e7a-87c7-38d38f54fa10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019ba4f1-180a-7b80-a9c9-db75c21a5709" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_EntityFileNumber_019ba4f1-180a-7b80-a9c9-db75c21a5709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019ba4f1-180a-786e-9d86-27bc737ac20b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_EntityTaxIdentificationNumber_019ba4f1-180a-786e-9d86-27bc737ac20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019ba4f1-180a-7b9d-8ecd-89a95c92def5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_EntityAddressAddressLine1_019ba4f1-180a-7b9d-8ecd-89a95c92def5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019ba4f1-180a-7835-84cd-0509194203b8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_EntityAddressCityOrTown_019ba4f1-180a-7835-84cd-0509194203b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019ba4f1-180a-7447-b805-4037ba202a37" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_EntityAddressStateOrProvince_019ba4f1-180a-7447-b805-4037ba202a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019ba4f1-180a-775c-ad36-09a601278cc8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_EntityAddressPostalZipCode_019ba4f1-180a-775c-ad36-09a601278cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019ba4f1-180a-7eb9-8169-833492415dda" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_CityAreaCode_019ba4f1-180a-7eb9-8169-833492415dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019ba4f1-180a-7f18-a9b2-6e1506b3db73" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_LocalPhoneNumber_019ba4f1-180a-7f18-a9b2-6e1506b3db73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_019ba4f1-180a-7609-82f3-e6f14ae3e65d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_WrittenCommunications_019ba4f1-180a-7609-82f3-e6f14ae3e65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_019ba4f1-180a-7385-b06a-0800021777c3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_SolicitingMaterial_019ba4f1-180a-7385-b06a-0800021777c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_019ba4f1-180a-7ccb-a304-2b12df6a2197" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_PreCommencementTenderOffer_019ba4f1-180a-7ccb-a304-2b12df6a2197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_019ba4f1-180a-7174-98cb-6c603b8e89ac" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_019ba4f1-180a-7174-98cb-6c603b8e89ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019ba4f1-180a-780e-aeed-65a61fd080c1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_EntityEmergingGrowthCompany_019ba4f1-180a-780e-aeed-65a61fd080c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019ba4f1-180a-7ec3-a6f0-b18dad9ca888" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_Security12bTitle_019ba4f1-180a-7ec3-a6f0-b18dad9ca888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019ba4f1-180a-7340-8ca0-56d01038854d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_TradingSymbol_019ba4f1-180a-7340-8ca0-56d01038854d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019ba4f1-180a-7dc7-8d0d-a0fefe7d6977" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ba4f1-180a-7c09-9f11-526ab94b2aa4" xlink:to="loc_dei_SecurityExchangeName_019ba4f1-180a-7dc7-8d0d-a0fefe7d6977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>guardantlogoa01.gif
<TEXT>
begin 644 guardantlogoa01.gif
M1TE&.#EA> 4H ?<               $! 00! @ ! @ ! A4"!!0"!!("!! "
M PX" PX" PP" P " P #!0 $!P %"  %"  %"3D'"P (#  )#P )#P *$  ,
M$P -%@ .&  /&0 /&@ /&@ 0&P 1'0 2'P 4(0 5(P 6);X7)  7)\\8)P 8
M*=<9*=49*=,9*-(9*- 9*-P:*@ :+  :+0 ;+^P<+>P<+>P<+>P<+>P<+>P<
M+>P<+>P<+>P<+>P<+>P<+>X<+>X<+>T<+>P<+>P<+>X<+>X<+?(<+N\<+N\<
M+N\<+N\<+N\<+N\<+N\<+N\<+N\<+N\<+NX<+>X<+>X<+>X<+>X<+>X<+>P<
M+>P<+>P<+?@=+_@=+_@=+_@=+_<=+_<=+_<=+_<=+_<=+_4=+_8=+P =,?L>
M,/L>,/H>,/H>+_D>+_H>,/D>+P >,@ ?-0 @-P A.0 C.P C.P C/  E/P F
M0  G0P I10 J1P J2  K20 K2@ L3  N3@ P40 R50 S5P S5P T6  V7  W
M70 W70 X7@ X7P Y8  Z8P [90 \9@ ]9P ^:@ ^:@ _:P _:P! ;0!!;@!"
M;P!#<0!$<P!%=0!%=@!&=P!'> !(>@!)? !*?0!*?@!+?P!+?P!+@ !,@0!-
M@P!.A !/A0!/A@!0AP!0AP!0B !1B@!1B@!1B@!2BP!2BP!2C !4C@!4CP!5
MD !6D@!7DP!7E !8E0!9E@!9E@!9EP!:F0!<G !=G@!=GP!=GP!>H !?H0!?
MH@!@H@!@HP!AI !AI !AI0!AI0!AI0!BI@!BIP!BIP!BIP!CJ0!CJ0!CJ0!C
MJ0!CJ !CJ !CJ !CJ !CJ !CJ !CJ !CJ0!CJ !DJ@!DJ@!DJ@!DJ@!EJP!E
MJP!EJP!EK !EK !EK !FK !FK0!FK0!FK@!GKP!GKP!GKP!IL0!IL@!IL@!I
MLP!JLP!JLP!JM !KM0!KM@!KM@!LMP!LMP!LN !LN !LN !MN0!MN@!MN0!N
MN@!NNP!NNP!NNP!NN@!NNB'Y! $     +     !X!2@!0 C^  $('$BPH,&#
M"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'$FRI,F3*%.J7,FRI<N7
M,&/*G$FSILV;.'/JW,FSI\^?0(,*'4JTJ-&C2),J72JT CIH4*-*G4JUJM6K
M6+-FF\6TJ]>O8,.*'4NVK-FS:-.J]3GA:=:W<./*G4L7;K98:_/JW<NWK]^_
M@ ,+'DP8(01S=1-?S8;+)09WBB-/[0:KL.7+F#-KWLRYL^?/*R&,DYRUF:Z^
M&=Z1OMKM%>C7L&/+GDV[MNW;&T>OELH+-P -\'9#[>;*M_'CR),K7\Z\N4C=
MJWLY=SAO=;=6T[-KW\Z]N_?O21W^>"/M"^R!,D'2#TD!MGID;]C!RY]/O[[]
M^_,==)-<?BP"].D%&.!Z9''@7EW>X*?@@@PVZ."#:.FG&#!H 2C@A1@.<58'
M!\[ES2K(P:"/<+NA,\E.</ 35SN,'&4'/G'!0PA0?= 3%3U](#5(<"0FAD\=
M.#G23H^)\=.&<:"0$Q4^)"RURGA0T?,!6K5D$]<Z%RQTBY5$=NEE5=XX4- P
M<F530$+(0&.F2!+6)4Q:_V$HYYSJJ9!6AW%]F!D*(W[IIV+HJ)3BBBT:]6*,
M,^[$QSU9X4C4CG]&&I4^<WPDI*286L7/&FDEF1631SV)U3P=A%7EE5DJM&6F
MK+XGID+^PW3SZD#&K%GKF0(ALZ:NN';$)5UOHI5 &G06:VP00]B)U@<V>@BB
M7GUV:4XF)ZVAXI?J2.+1H'"QZ"*,<,F8$Z-UT1,4I*VR2NE%EZ;K[E7\C)'4
M)XC1!>I0HLXUSU*GPH6EEK^^*[!580(5<%S!GC7LL0PW/,0*:3'K(2ICF1"M
M8M,BQ<:UI*D3247<ON6MH>"^)2Y-B^[F*$_HOG5/'C$E ME<^L@Q4;M9\0,'
M3Y2X)1D_,?A4[VKXC !4OI+M.U2_;_U+DR[-Q&6.!(05</!;PPA+;,-<=XTL
MQ&=)G"?%2UF<F#F;Y,6Q5-EV%')6(Q=U:+B)OI3RERO?U'+^5B_7)+-<-4>$
M,U8Z'^4S74#31*^?]QB]$](]*KT3TUDY/1/44E,=F-5T94V6 FAX+?KH 19A
MEMAP>4,V41?#94XGVKV-5=Q$S6URW2K='5?> M4XE[DU[8U5WW[/_%;@$ T.
M[\Y,67(X7(FOU,G0<-T[D*=RW9,3Y*-. ,!^=<VS@4V48V6Y3)B[KOE?G,OE
M>5B@DR[__.D5P<)8(#2;^NH]D5"RZ[#KCNRN0KNAV"XK)T,)N>(RCS\T1']P
MX9U+A'<5XLGD;W%!7O*&]);"@>42S\N92:9'LR8M!'MQN8<(:L*]JY *(>"C
M"SPT\)+R7>5\,4G?6Z8&F/;%Y7W^3%G %NA'Q"*6[GY>R9]<5->__V7E=?(9
MH%4**)0#8B6!(]G# M_20(KX+GM\F""/7 8SEF"P+OJHB/(TQ3RQ@# NT?L(
M]8YG HJ@$"XJC$D+K?)"A\1P+C-$B0VM@D.8Z/")Z^O+U; "1*0(T8B0C&3]
M6L 4)>Z/)_Z3"Q2CN+;9%4IN3KP*%CVB17UQY(LI#&-**#@PX:PK(VNLB@?'
M\D;HP8 CFYAC5M*XD5! !X\K9,D>J])'BOQ1+H$$R2"K4LB7'!(K//2+#^'2
MR*$\4I+8S&81*'D42[Z%B3O)I-0".)0Q=+*55U$')!HBQ:I0,2A6%"7N-%)*
MN<P#$"/^@2 >3\)*=.Z2#B:))55F2<L06D4?M[1(+FE61Y'X,GO!1,DPJ5),
MC1PS+N_(@$:6295FNN295XFF-!=IE6K^9 %>R*9*5UJ_$PS%F]_D7T[$"4"B
MF-.?65&G0]I)E7<")9Y6&:5%MHC3W=Q#E2'I)U4L6)!"C%$N/]J)0*="T+#4
MLH,)E4@F=%E4R>2Q)!.=2D5!<E&X9'0B')V*1UL"4JN(U"\D+6E04,K2NK*T
M""[]"4RS LXFSF63F6G#.=.Y3G8.UIV?K%TH@SI/B=2SJU\ZZD>4.A6F*L00
MJJ&+/H!$DZE*I:I?N6K.@@:1K4+V3U\%25BE,E:3Q!4K[M#^Z$+2*I6ULJ2M
M57GK2.=BTIO0U:[ U69>>;)7K/05*"1HW1/).1C!RL5C$>&I5'SZ$Z!21:@.
M>2P7 Z&3/^");QRAK%0L^Q#,HI&S+?%L5$"[%-&.%B)<Q0HO<3**7[KL(ZN-
M2FM7(HO77L4=&"@(;:-BVY7@EBJZ_8M_J=);FOPVN! V(EYYHD^^RG0H9J,+
MVOQR6*M =R+2G4H[0(DHB.B!J%F1W$^^.[P]8$2\42$O10Z169H!%"7JA0I[
MC>*\N<21(:8%' J"4M_LA6 C^87*?F/2WT@56"4'GDJ">[C@J23,MRF-L);E
M-^&<H.Z27LEP738LEHTE1AT:"?'^=!.[$^M6!1Z%> B*1\5=I+"X@BZ>"(RA
M(N.,',)X@+MQ2'(,C1W[I,=U^?%"@IS!(1^E%/;EVY$MDF1H+/DFLZBR7)Z<
MDBA+9<J"F29<KFR3+&_YU,?J\DTJ;.&T*/=LU/*)F2/3-I'$X=59<0>;65*'
MQ2(PS@XYL3WK[!5 W-DJ]\BS0_8,C3Y[!!& SF"E.$)H0\-D$@8M$FD?PFBX
MZ.,%8('T7.XQZ8A4^M(]R71D.(T23T<%U%4K:U9([> AHOK>0=@F3CB$H&?]
MA4^M0@<F(')33*$9)K?ND3L4$9$ZX%HQ[P#V0_(P9Q>BQ=CC;@BSG3V2,P)N
MVFKDX&G^,14OBV3[H. ^B[A36.Z&G+M43!DP5-A]$G=#!=Z7:1-=*)23:^);
MF]R\";_[_9H7/'SD63&14>1P='2^PQ 7H3@@B9T7C*=0V0;9>!EAXO$,VFR#
M2"<-/T*"B9-3Y=M]044XC,R0EY/%%HNDN4EL#@V<;T;G.^=)_'[.-?OQY-A\
MC4]]8M#AJZ##$K:A0^O<D0@(.?[QD(]\4<03F?X(96$J3191 /]-P4O^\Z /
MO>A'3_J)4)XTTF'0!C@/EVZ4_O6PC[WL9__Y!T1:,;UI#G"$<QW:^_[WP ^^
M\,%S>]*81C-/)1%QAL_\YCO_^= _3GR]Q)BB9"#:D7)]]+?^S_WN>__[H)'
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MB9%,&Y&EAK2E(=6E>G&>8:H3#T:F$&:F0H&F:1I.<_II;?H3!5=^.L40,&I
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M3F,[VK"_W\ _E-,0$HPA?EB#ML $ )0Y 30M5 B'$".) [0<6U@E!;P,!MS
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M;/HA:] 2;$BNA5B22]0N;:4T;9=*0F'$P>#VVWY4K;9<;$5DK+7P#=?:)4R
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MS8J*+?062=N%29_TC:AT/+?TEM4Q@>CRC7B#3+]R0PCT+]_^M*:XM<;Q]%)
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9!Q8\F'!APX<1)U:\F'%CQX\A1Y9\,R  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Jan. 11, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 11,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GUARDANT HEALTH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001576280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-4139254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3100 Hanover Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">698-8887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.00001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="gh-20260111.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://guardanthealth.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="gh-20260111.htm">gh-20260111.htm</File>
    <File>gh-20260111.xsd</File>
    <File>gh-20260111_lab.xml</File>
    <File>gh-20260111_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gh-20260111.htm": {
   "nsprefix": "gh",
   "nsuri": "http://guardanthealth.com/20260111",
   "dts": {
    "inline": {
     "local": [
      "gh-20260111.htm"
     ]
    },
    "schema": {
     "local": [
      "gh-20260111.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gh-20260111_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gh-20260111_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://guardanthealth.com/role/DocumentandEntityInformationDocument",
     "longName": "0000001 - Document - Document and Entity Information Document",
     "shortName": "Document and Entity Information Document",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gh-20260111.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gh-20260111.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://guardanthealth.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001576280-26-000004-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001576280-26-000004-xbrl.zip
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MD; @,_78^?*T!!%& Z@)&Z(O*G<8/%JSQ&_.0*?[KS"=\0U2GTX>UMGD;RF
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MRP_);O ;"+ON7PW:Y7^MZ']02P,$%     @ G# L7$OPF9=%$   U7@   \
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MLVYI'BYCIU9QJU7++GJ-NEDQ[6H=5_M]VRY[ Z=?<>LUT[-,8U#QRI::=R0
M9\ [X.>%D1!1HU2:3";ZI*R';%@R'<<I366?0M*I0:=BI>.TSWS5E08^#8@D
M3$DP''")-Q9 R1+@:FB&I9G6TB :)^[*0/"L#\/[1\<Q*X"R5C87XVR&!7J6
MEP;*ND\YW82D91AFZ:^KSSUW1,98HP$7.'!)]I5'%E^I&3)(H4'B5ID/#XUT
M&T"&!&AU8 #OZR/=97,?\WGWZ5K_E462K:IKP\? KP42:%]ZA>;9B&"O>38F
M B/YJ4;^B>G]>:$5!@)X5[N;13"#FSR=%P29BI):[U+SEU]^.1-4^*0Y'&F2
M80W3-,]*R:NS4C)P/_1FS3./WB,N9CXY+WB41SZ>-8(P(# ]G39D1\*2G]3S
M2*!^0OLUB ^C;C+[5'3)X+S@:K"Z 1[+D0AMM .8;M8"V!CV.X%'IG^060%1
M[[PPT"RKT#1@\2JUJE4WSDHKH^XPR05(L2<E^8./A_/!RX7F /N<K(U;6D6$
MD0%AH"<(WT!]N2H-KA@+9D9JE1H":'Y>X'0<^7)UU;L1DX M$5J?<@\60<VV
MF"*=D8<Q4T^*YQHI;@IRB5OVGBCJ94_4D\\#2AA2$)&-\M?J_+%*U8<?-[-7
MJZ-'0)S0RYZ TYFX!*W8E/AH!J@T,_MNT38'T]O2-6O)GK-)2BMX9T2:4Z6T
MQ'4EX,V$025UZ%-*\?\D]1;?I$P]IH$V(E)S-VI6)$XGU!.CAFD8_U-0_9IG
M/,+ #GTF5RSYG0RR-I14?!H S; K&CP>CS&;G4HL-.S38=!P@:R$P; "]WV2
M?=4/&6"CN:'OXXB31O;C-!.W1-MIZJ-3&',($/=#(<)QHP( @U43U,5^.HF:
M+VE.<7$<O5RI2W0$$$UXV<0IICI@6EI_[]1UQ]C<9.BF>E]2X[&L,:6B:4>B
MH#X"3"2]S@OEP@-D4_#-2" >^M1#OQKJWVF$/6F3&P:"MOD<)87[!HIO(JZ<
M,FL'"$+6R 8? $]I SRF_JSQ[HZ.0:ROR01UPS$.WA4Y,. @Z</I?XC"(WF<
MI.P!0ZB5F"-J U&_7'?NVI>H=W=QU^ZM,LAQ =IKM[YT.W>==@]=7%^B]E^M
M3Q?7']NH=7-UU>GU.C?7QPS]GYB/@#%$&!31I=[2P<VJV$X&\;Z <7+!\MNO
M9M4XW4JM5$1%&"GY/+P" &6F&XE".[P&V"SA/[L6^7#3O4+YW9HL/DE<O,2K
M >M6U_YXZ-*@-S9]8],<;&KD8E.P(-WV]1WJMF]ONG>'L1?Y(+V-&8\Q1/ B
M1#WBRB@S4=MF&84,F943[_TQPQ\.5+H!0(\9%13&;$_=$00@!%VX D&SZ93M
MX\# WHB!].XEG(Q$(1/H)'LF&/Q[P@4B]S+#DC03[WWC&?KO5@4-[224** D
MH0"AP%0T/'BCC6&(D?Q,\_!,F\'4&@GF86"A^6\<Q."D(],LJKS->D#XICS?
ME.>3 E'-)=*[ID:Z9$BY3)2):VC)N+9<:'[\<M&]O  U_*E]\?GN4Q%UKEMZ
M?L/_DJ2HYZ+$27L*(;)".-$0&:((<\0CXLILA(=H@*C@"-0>* BV75T?G3#^
M@!'W=Z+/RH9>LQ^G8=[W,$5]MY&V F7JM2<6]BB!VH?F/^9N*7Y/];>BJ?QB
M6:_X9+#&PPG[%C9III3Q97HQ'523(S0LW:HLO5/[1]G+P_J@B>3M:+ Z@1LR
M\.;4GDY/@ /6"N- L%DK]%:],YDIE<EB02(6WLMQ%FZ9#:XC\?$$LPWY^97\
MJ_#VQ!$;5CBA^=8U/O*5^$!] IW[P#4I52LR\V]JY7JU7MY*UI<DZ)O(;%JH
M.SSMI-LOKA*;U56K%IIV1;/-LF-5[!S2\*:Q]\]^2][E&C>:NFFM<6/Z\J!N
MMF+&$Z6#9;HC%"/"T-\QH]RC*AGRE#/]0Q  8@NZ;),4*=@0!_0_ZOG]*QJ4
MGY(!6^%X3#G_6?A-FEV4:/ WUGIAUNKH7;VGH_8X\L,983\%?ZVZ"N@ZU#>Q
MV3'O(EC/<9(N/(\1SM/_/L-X9N8@U0K-,M &?<)!"!* >H(1(HXC%Y8ST_],
M:K3@YPV["R?SP*E>:-YB/T07O@@?4J"X0W)]91KE0MRP6PC3J"IPRQG%.85F
M"^@*O0.*U]?C><#<AC";_[\T2@+*=-_3*#0=NVRL^<='O>HG*4HR_QDQ("V-
ML(_(E+BQH/<R+0IB3OA[= +H(HGO46]7Y5]0R;<7C."5)91[UY7*PP74\H_Z
M.033=SL*@P=AKVGM MO64<J%9M6I:_5ZO;:Q9O"[X;K%GL)OO]8MLW;*D2 ^
MB23.*%!(%Z7/[,<>01B6"<CU&.N]I=Y?(_7^RCNWK1%QOZKM9QR!9@?U),/(
M?CA%?>*'$T23O>D/8 E07?L##2B,,424 ^<($GC$D[ONG(YC7^" A#'W9XB#
MS\(',_5E^D'8AT5, [-DR*6=H!C&80@'LZQM *P23N1WTMI0&53P1D[&_%ZV
M8RU@P^I>TON.K=<=^UC2^_O-V\"B[BMGF%\%7X 4^.A+0*5"1%<]D"X<<&U-
MQ*RG1&S'/.&?C H0*AE)QT'J^?-U-ZP?AGX?@X0(D-.YW;)EL:)3L^W3;TZE
M'_/:[$'QJ55):0UD6"8VBI9JB;HQ:!';JJ3ZZ4&-CBS-.3%KJ/6ABZRRH4/'
MK1':FS@\1QQZ8$%=('8PO *C)('(*PN5-UG81186A$;CE-+K@F#:&%SL)5E8
M*5*;2X(-)D?U?!.&O0K#+2/2+LCC0ZH:6/I>[&8PD)%+/J&HO@G%+D(!!-?<
M)8H_:2E,V].LD_[[?"*2]'T3DI<4D@[G,6'/$)7:FZB\K*B4B6:?N/E$)>W[
M3>GOOV,NZ&!6V'[";UOP;9FF9Y)]T\TR'&EW%]YD$@T3!O%TM%[.CDRE6-+H
M&"B4-Q@^@BS-<ZO[*GI-)G?V$!^;#LB%M9>A;%.O.KF21V]E,ULVMN[DP?/D
M<( [0JZ/.7\II?H#$H]A"1?JS<;]T#_ANV\]_[2DNTXKT!7;D<S:@&Z=C"B\
M62C@%W?)?CS:[A#3)R9O9EI]I0CF+E>]T)2N&ZQ'3X3NUR+Z;V4V#!-%F*%[
M[,<$1?+.@]$^BD7?5NK)E4I53:)IYLOD%)H?/QTQ^0]5U/%B@I+YQ<FYH(?A
MB]1CJYOQE@%6 IS$:\P]_ _ZZ(<0WH ?Z8,GB:XP^[I>,K&S8[VZ!M75.IL'
MZYK+\_[V@5]QRZP3>#*R(:@_0Z[:/@,@OX(9(:KR\L'>%N4(H(.P2.(Q1$,6
M3L1(!DB1W._"''ED %.H$U!)PMFHH/43H8N#H&5T(D^WUDY5TCGK3-79J4B>
MG9*5CW*D] RLU=>LY&>^<Z9)WVP.&8 ]&&%I*CW/!OC!%JJ]F>@)*JL7.^PY
MKY$/OETK8S)\/BIT6@DV.5,:EOED2N.55R=7\<1.VN,8>*XS>$3<9;G%1MU!
MU[;$1Z 9E,X&S1"$*A<0<Z)Z 9;IQKN\6(VJ_$!RHY)D!367/Y.3JXOLI)8)
M "UH8>2><O@.] T.7,G)V'7EJ1W965YJYF'F\63+W=N<B,C.U9_@>39B68?H
M1R-;<U[?F.-Y- &TDXVJK]HHYQG&[]M!6K[3*@H3EF@PXF-97K9VR]4B\Z,P
M,!:?X#X/_5BL?_+4Q5B[WLY5F]_.-6(+WW!(M#XC^*N&!V!<&MB?X!F7*95E
MZK_L%5ZOZA&:%:DP!!DC2S<L?>]Z^&%V?3, "+VX =@\<9?PV!>J*O(&]%>:
M*P8MA#[,%50K!(6I&@Y$'7W=3'T/MLBT /:; #V\]**(/L*S)Y7Z)X)],2JB
M3N#JZ$1J<EDF:!FGK<Q-@B?S]#VL2 !&P@6#X$)XAL%/C4"W4)!$.7(<X!B6
M:,6LT&!^W:<R27+P?V)ULE^M[R#V?21OZ$")(;LD+I'EB*B<@%G1T078L6A>
M#Q:I\EF8E6 P@N" ]HFT68.8!92/8 0L?=D1[5.!'$<WI<52CFHK9DQN2'23
MBTD GJR2[1FNZR[;!B^N,FJZ8?Z$*F,8^PE??;A$EY2[?LACF0\ZC'+X?G6#
M3!&D@@Y^(H@C. %B+FL@,@F5Q0A#""O2+DD+PDE'=?GQO_5;'5VI@W:I1G$Q
MDT,'Z5VG4N;F6LA*M% BGG, YN7)$]('3X04D;S)=)@JJI$:50>WMH@41'-%
MU9:7"G'T&QY'I^AV"6R>ZBXD?8JE/<;TNTYP3[@(V;R;P/W]J8-C6^4593Q7
MF#1X2D%FM>%2T2[KUJ),P0(WR*BD3Y!'(-CQ,M(.J$^\C*Q2]4,, 9Q%E)6?
M;V;6-R0X-J4BBE*OXW%B))9-U'+GS$X5YX=?)Q#E(![W_Y8IKY35?(K[U$^F
M4I,#$Z?P% $5EB)%EW&"3_MDZ50IO(*P;7Z+KZR #E5\E=4X#Y:Y>GO58)K'
M6<9. ?\PFBK*;0H2J9MRR%390%E<382D+(1V $QZ@8Z[ A7@[HY2H/;/UX_F
MZ*HO6WZP^8R9M(=)R.F 441+[J,ZT3166D+Z'2D;\^U$.21R:R*LD#OQWG\K
MW*;Y_53%UW3;VL_U.89>L6M[V?2O.WJU7'ZA3?]7NGRDIE=R;5!DFOXZ7##;
MP<XSOS;REX2[C$8K=R;DV/Y-92G=H]AR\"?WTB>58*]<P24-^_[6>RM!'J/&
M4QN 6VDR&+P$31+0/.*F]TDTE#F7O0 <O#&'1!+9.3TD;&C^%P@,< &ELSU-
MP7(<4Q^)L:K6@V"ZFP;3X(QL3 D4D:<\GO5K,_$CM]$<KP+,*0BF8?\X>B\G
MSBUUG/Y6QDH=N1; R_)8\B46&*EK+DYD=L;STK^-0Y,@K*,<!*3^AHZ7WM'Z
M?I/:?(U#9R]W-^EK0+3E&.B/EO67I_</G_9_RL4_<)F(<OI[G8_7%W=?NNW>
MDW>Z/V,?ZA6CE^6KN9,=SG]BRM*0;/<D0''3-JD70U3LXEAN;:J<1GH+=1*^
M<\ ?&L+D?MD^@3!_("-G.9 RFVF'$83/L0SHU7 X%J.0 :+>A@V W$'7$51?
M@V-7,9U=H["*7C'V4S!M0>Q4V<\Q9ULW]E3%7:GJY?U4<7^+5:@>KY^P.3S:
M<A?UTQ:_<O1W$KY0@>\K.W+R9OS&#N[KD:/S<-O@Q\'L]]D/M$PE7D)7% PW
M\='OQ/=W29T<1/J?FZ_9L43Y$"ECM2 ;%V/G4/T@"OG(6;TUHF2PM+]PHV[N
M8D?/\=\)>4]NY[>C72PJ$U,BJQV<18>U1=B0>_BNX^I2\C=9U9]Q;?X_4$L#
M!!0    ( )PP+%Q>+)0/>P(  %H'   /    9V@M,C R-C Q,3$N>'-DS53+
M;MLP$+S[*UB=2TNR%+\0.T"3!@C@/I F:&X%+:TD(A2IDE1L_WU)6HSMN GB
MGJH3M3LSG%TN>7ZQKAEZ JFHX+,@[D<! IZ)G/)R%MS?7>-Q<#'O]<X_8/SP
MZ7:!KD36UL UNI1 -.1H176%= 7HIY"/](F@[XSH0L@:X[FC78IF(VE9:32(
M!D,/\UDYC>+)DJ1%C.-Q1/!H-"9XDHY3O$R %'&4#<=Y^K&<%E$R'*5D@*-Q
ME.,T2@!/XO$ YR0AD]%9-AP.4B>Z5E.555 39$KC:KI6LZ#2NIF&X6JUZJ^2
MOI!E.(BB.'SXLOCAH$&'990_'J#72\D\/@EM>DD4>'A9/8/+ELB<<-,(PG35
MST0=VG*C.(X#1+26=-EJN#9]N8*"M$S/@I;_;@FC!87<-)V!;>L!8"^MB2Q!
M?R4UJ(9D\*YMYSV$;#=HW0BI$3\B'Q=(N=*$9Z; ;0L7(B/:3<:K%/N'/0_;
M$(X'.(G[:Y4'X3]XV#7Y- ^>=[H')Z8@ZY?B*<R!VA:>_7U[]1K<+K!='.Y)
M.!?:\6VDBS4-Y878!DS(&I]Z][=0^+D]&L9N=./)9!*ZK)E#1R8RDX+!V^"P
MD:(!J2FH_4%V I6$8A:4%?;#\ZN1T#<^/.!(_O  ;-KH@S(C[*I=[,KQ$GK3
M& EE3H'!MD'_;_6,+$^MWE" G5BV)=Z9/*+Y+/ O*^'Y9ZZIWMQP^XRZ=OI<
M@"SE_O;FK0? V7F7FG?C_>104$[=M$;NBQ'>O?A[2Z.*MK)H3_<Y?QZ^E'NQ
M4:L@_\;G;OUR;#IR!WF#F!&6M>QTWL[6J[0NZ,^GN[OAX>7=_N]=<!?8OAKS
MWA]02P,$%     @ G# L7.PM_I]#"0  ?54  !,   !G:"TR,#(V,#$Q,5]L
M86(N>&ULQ9QK;Z-(%H:_YU?4>K_L2E,Q]TO4R:@WTSV*-M,===*:T:Y645%4
MV:@Q1&5R^_=;8#L!4T!58=-?$L<NG_>\)SP^!PQ\^/5EE8(GPM9)GIW/S%-C
M!DB&\SC)%N>S[W>?83#[]>+DY,/?(/SK7]^NP6\Y?ER1K "7C*""Q. Y*9:@
M6!+P9\Y^)$\(W*2HH#E;07A1O>TR?WAER6)9 ,NPO-VRW:OLS###"#G4A&9@
M(.C[ 8*A$S@PL@FBIH&]('9^69Q1P_9\!UG0"(P8.H9-8&@&%HR1C4+?Q9YG
M.570-,E^G)4_(K0F@-O+UM6?Y[-E43R<S>?/S\^G+Q%+3W.VF%N&8<]WJV?;
MY2^M]<]VM=H,PW!>O?JV=)V(%O*PYORO/ZYO\9*L$$RR=8$R7 JLD[-U]>1U
MCE%157TP+]"YHOP+[I;!\BEH6M V3U_6\>SB!(!-.5B>DF^$@O+W]V]7G9+A
MO%PQS\BB_-_>$);D\6V!6'&-(I+R[*MHQ>L#.9^MD]5#2G;/+1FAXK I8XVH
M999AF:7IE5G^O4ML/B+] ^5;M',]0'*5W2^'RK&OIE\.ENX=_X0@QT^X)C,Z
MY<T&]2F+I]IVWZ1&IW[\C ^U6>0%2B?8+-YE:BFGY1/7_-%6I@S4\V%:Z6P_
MNFNIDI>"9#'9?%HV0H,D/I_Q1_<Q2>YO\S3!2<';XA\\(Y:@]'Z_<1$/!EX0
M0H^6K<M&9FS8]\7;%GU/,OC]=B=>*?2%GRFX*CKH9&2=/S*\Z6M<LNSIFRPN
MW@7!3O'#_#TSY6*D1[:8'LU=CAM1T[(MYVS?1(X'3+QOY&ONHG*P)OATD3_-
M^1NY$\LM'\#R0;5M=X2;MTK_D>TR1 P/U&J[8HYS/FT\%+!1-LKRE8R5(I?Y
MKVW*Q05G(&<Q87QZ%"3?V&[^9$G!:;O,5ZO'+-F,/^M]CES#@)%C>=!R73?
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M<[U[*]0#37=K!4'ZC3LKB%[O0J%>4=Y%?ER<[)Y)-G?KO#CY/U!+ P04
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MU&K864>E G%"W2&*8A'&)'$%^; /,3]HZT< CWN8+X9NSR%OOJ?F%XNR>*:
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MM-REM1\'/&X[#H9R-"J\FG8P/'<#)P>/%YI#L]O^Y. ?4$L! A0#%     @
MG# L7!2&6K-1#P  M&@  !H              ( !     &=H+3 Q,3(R,#(V
M>&5X:&EB:70Y.3$N:'1M4$L! A0#%     @ G# L7$OPF9=%$   U7@   \
M             ( !B0\  &=H+3(P,C8P,3$Q+FAT;5!+ 0(4 Q0    ( )PP
M+%Q>+)0/>P(  %H'   /              "  ?L?  !G:"TR,#(V,#$Q,2YX
M<V102P$"% ,4    " "<,"Q<["W^GT,)  !]50  $P              @ &C
M(@  9V@M,C R-C Q,3%?;&%B+GAM;%!+ 0(4 Q0    ( )PP+%S\*^WK\@4
M #TQ   3              "  1<L  !G:"TR,#(V,#$Q,5]P<F4N>&UL4$L%
3!@     %  4 1 $  #HR      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>gh-20260111_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gh-20260111.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001576280</identifier>
        </entity>
        <period>
            <startDate>2026-01-11</startDate>
            <endDate>2026-01-11</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001576280</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2026-01-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">GUARDANT HEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38683</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">45-4139254</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">3100 Hanover Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">94304</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">855</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">698-8887</dei:LocalPhoneNumber>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">698-8887</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, $0.00001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">GH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
